Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2005 2
2006 3
2007 1
2008 2
2009 3
2010 2
2011 4
2012 4
2013 4
2014 5
2015 5
2016 8
2017 9
2018 10
2019 9
2020 12
2021 16
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Results by year
Filters applied: . Clear all
Page 1
Alcoholic liver disease: Utility of animal models.
Lamas-Paz A, Hao F, Nelson LJ, Vázquez MT, Canals S, Gómez Del Moral M, Martínez-Naves E, Nevzorova YA, Cubero FJ. Lamas-Paz A, et al. Among authors: cubero fj. World J Gastroenterol. 2018 Dec 7;24(45):5063-5075. doi: 10.3748/wjg.v24.i45.5063. World J Gastroenterol. 2018. PMID: 30568384 Free PMC article. Review.
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
Colyn L, Bárcena-Varela M, Álvarez-Sola G, Latasa MU, Uriarte I, Santamaría E, Herranz JM, Santos-Laso A, Arechederra M, Ruiz de Gauna M, Aspichueta P, Canale M, Casadei-Gardini A, Francesconi M, Carotti S, Morini S, Nelson LJ, Iraburu MJ, Chen C, Sangro B, Marin JJG, Martinez-Chantar ML, Banales JM, Arnes-Benito R, Huch M, Patino JM, Dar AA, Nosrati M, Oyarzábal J, Prósper F, Urman J, Cubero FJ, Trautwein C, Berasain C, Fernandez-Barrena MG, Avila MA. Colyn L, et al. Among authors: cubero fj. Hepatology. 2021 Jun;73(6):2380-2396. doi: 10.1002/hep.31642. Hepatology. 2021. PMID: 33222246
p38γ is essential for cell cycle progression and liver tumorigenesis.
Tomás-Loba A, Manieri E, González-Terán B, Mora A, Leiva-Vega L, Santamans AM, Romero-Becerra R, Rodríguez E, Pintor-Chocano A, Feixas F, López JA, Caballero B, Trakala M, Blanco Ó, Torres JL, Hernández-Cosido L, Montalvo-Romeral V, Matesanz N, Roche-Molina M, Bernal JA, Mischo H, León M, Caballero A, Miranda-Saavedra D, Ruiz-Cabello J, Nevzorova YA, Cubero FJ, Bravo J, Vázquez J, Malumbres M, Marcos M, Osuna S, Sabio G. Tomás-Loba A, et al. Among authors: cubero fj. Nature. 2019 Apr;568(7753):557-560. doi: 10.1038/s41586-019-1112-8. Epub 2019 Apr 10. Nature. 2019. PMID: 30971822
Reply.
Cubero FJ, Zoubek ME, Trautwein C. Cubero FJ, et al. Gastroenterology. 2016 Aug;151(2):372-3. doi: 10.1053/j.gastro.2016.06.048. Epub 2016 Jul 1. Gastroenterology. 2016. PMID: 27376523 No abstract available.
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
Liao L, Schneider KM, Galvez EJC, Frissen M, Marschall HU, Su H, Hatting M, Wahlström A, Haybaeck J, Puchas P, Mohs A, Peng J, Bergheim I, Nier A, Hennings J, Reißing J, Zimmermann HW, Longerich T, Strowig T, Liedtke C, Cubero FJ, Trautwein C. Liao L, et al. Among authors: cubero fj. Gut. 2019 Aug;68(8):1477-1492. doi: 10.1136/gutjnl-2018-316670. Epub 2019 Mar 14. Gut. 2019. PMID: 30872395
Alcohol and liver fibrosis.
Cubero FJ, Urtasun R, Nieto N. Cubero FJ, et al. Semin Liver Dis. 2009 May;29(2):211-21. doi: 10.1055/s-0029-1214376. Epub 2009 Apr 22. Semin Liver Dis. 2009. PMID: 19387920 Review.
Guidelines and Considerations for Metabolic Tolerance Tests in Mice.
Benedé-Ubieto R, Estévez-Vázquez O, Ramadori P, Cubero FJ, Nevzorova YA. Benedé-Ubieto R, et al. Among authors: cubero fj. Diabetes Metab Syndr Obes. 2020 Feb 18;13:439-450. doi: 10.2147/DMSO.S234665. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32110077 Free PMC article. Review.
87 results